Health Care Company Acquires Precision Dosing Software Company

December 5, 2018

Tabula Rasa HealthCare, Inc, a health care technology company has announced it has executed an agreement to acquire the Australia-based company DoseMe, which developed DoseMeRx—a precision dosing software designed to predict the optimal dose of drugs.

Currently, DoseMeRx is available in over 100 hospitals and infusion providers worldwide. According to Tabula Rasa Healthcare, DoseMeRx will be combined with its Medication Risk Mitigation (MRM) technologies in order to enhance medication safety solutions available in hospital settings.

“With DoseMe’s state-of-the-art decision support tool combined with our ability to predict and prevent harmful drug interactions through tools such as the MRM Matrix®, we are now able to offer hospitals a broader range of protection against adverse drug events, the fourth leading cause of death in the US,” Calvin H. Knowlton, PhD, chairman and CEO of Tabula Rasa Healthcare, said in a statement. “Together, we can power the shift to precision prescribing, tailoring medication to meet individual needs and tolerances, which will have a profound impact on safety, quality, and costs, such as medication-related increased hospital length-of-stay.”

According to Tabula Rasa Healthcare, “over 2 million serious adverse drug events occur in hospitals in the US alone, costing an estimated $177 billion—more than the total cost of cardiovascular or diabetic care across the US.”

DoseMeRx will create a virtual model of each patient based on their specific pharmacokinetics, such as the patient’s ability to absorb, metabolize, distribute and eliminate a therapeutic drug. The software then uses the virtual model to determine potential outcomes of different dosing regimens to ensure that the optimal dose is achieved.

“By joining Tabula Rasa HealthCare, we are able to more effectively combat the growing problem of adverse drug events, most of which can be prevented through better medication monitoring and dosing,” Charles Cornish, CEO of DoseMe, said in a statement.  “We look forward to working with TRHC to provide clinicians with the tools they need to optimize medication therapy and improve patients’ quality of life.”

The acquisition is expected to close in the first quarter of 2019.

Julie Gould


Tabula Rasa Healthcare. Tabula Rasa HealthCare to Acquire DoseMe, a Precision Dosing Software Company. Published December 3, 2018. Accessed December 5, 2018.

For more articles by IH Executive, click here

For similar articles by First Report Managed Care, click here